A biotech that uses artificial intelligence to assist its drug discovery efforts has relocated its headquarters from New York ...

The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

The UAE BioTech Symposium will be hosted in partnership with AmCham Abu Dhabi's BioTech Committee and Masdar City <li /> T ...

Insilico Medicine reported Phase 2a results for its lead program, saying the study achieved its primary endpoint of safety ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results ...

The world’s largest technology exhibition, GITEX GLOBAL, returns for its 44th edition, bringing together tech innovators, ...

Ins("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in-class small molecule ...

But Bamlanivimab isn't alone in showcasing AI's potential. Insilico Medicine, another poster child for AI in drug discovery, ...

Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in-class ...

A new generation of longevity biotech companies with a more conservative approach than their predecessors has emerged—but ...